Ofer Levy
31Patents
3h-index
64Co-inventors
66Inventor score
Filing activity: Apr 1, 1999 → May 12, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8529943B2 | Angiopoietin derived peptides | Chemistry; Metallurgy | 10 | Active |
| US8415455B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 5 | Active |
| US9538852B2 | Stabilizing apparatus for inclined legs | Human Necessities | 5 | Active |
| US9107862B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 3 | Active |
| US9375466B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 3 | Active |
| US10098934B2 | Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics | Physics | 1 | Active |
| US6153584A | Therapeutic uses of BPI protein products in BPI-deficient humans | Human Necessities | 1 | Expired |
| US10731129B2 | Methods of evaluating immunogenicity of an agent using an artificial tissue construct | Chemistry; Metallurgy | 1 | Active |
| US10550173B2 | PVRIG polypeptides and methods of treatment | Emerging Cross-Sectional Technologies | 1 | Active |
| US6376465B1 | Therapeutic uses of BPI protein products in BPI-deficient humans | Human Necessities | 1 | Expired |
| US12268739B2 | Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune response | Emerging Cross-Sectional Technologies | 0 | Active |
| US10881729B2 | Vaccine adjuvant compositions | Chemistry; Metallurgy | 0 | Active |
| US11655297B2 | ILDR2 antagonists and combinations thereof | Chemistry; Metallurgy | 0 | Active |
| US9255132B2 | Angiopoietin derived peptides | Chemistry; Metallurgy | 0 | Active |
| US9770483B2 | BPI and its congeners as radiation mitigators and radiation protectors | Human Necessities | 0 | Active |
| US12367992B2 | Multi-cable interconnect connection system | Electricity | 0 | Active |
| US9884089B2 | BPI and its congeners as radiation mitigators and radiation protectors | Human Necessities | 0 | Active |
| US10736753B2 | Implant delivery system | Human Necessities | 0 | Active |
| US11464854B2 | Methods and compositions relating to adjuvants | Human Necessities | 0 | Active |
| US12155979B2 | Cable pillar for director switch systems | Electricity | 0 | Active |
| US8575107B2 | Clusterin derived peptide | Human Necessities | 0 | Active |
| US7041644B2 | Therapeutic uses of BPI protein products in BPI-deficient humans | Human Necessities | 0 | Expired |
| US11633473B2 | Stimulator of Interferon Genes (STING) ligands and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12069829B2 | Dual connect switch module | Electricity | 0 | Active |
| US10493134B2 | Compositions comprising collagen and PRP for tissue regeneration | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.